MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Total Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Liabilities | ₹27,652 Cr | ₹11,883 Cr | ₹9,686 Cr | ₹9,108 Cr | ₹6,324 Cr |
What is the latest Total Liabilities ratio of MANKIND PHARMA ?
Year | Total Liabilities |
---|---|
Mar2025 | ₹27,652 Cr |
Mar2024 | ₹11,883 Cr |
Mar2023 | ₹9,686 Cr |
Mar2022 | ₹9,108 Cr |
Mar2021 | ₹6,324 Cr |
How is Total Liabilities of MANKIND PHARMA Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹27,652 Cr | 132.70 | |
Mar2024 | ₹11,883 Cr | 22.68 | |
Mar2023 | ₹9,686 Cr | 6.34 | |
Mar2022 | ₹9,108 Cr | 44.04 | |
Mar2021 | ₹6,324 Cr | - |
Compare Total Liabilities of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹101,751.2 Cr | -4.8% | -10% | 14.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹393,383.0 Cr | 1.8% | -3.6% | -7.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,026.0 Cr | -2.8% | -12.1% | 24% | Stock Analytics | |
CIPLA | ₹126,159.0 Cr | 2.3% | 2.4% | -4.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,450.0 Cr | 2.9% | 6.5% | 8.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,536.0 Cr | 2% | -2.4% | -13.1% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | -4.8% |
-10% |
14.1% |
SENSEX | -0% |
-2.1% |
1.1% |
You may also like the below Video Courses